Summary
The effect of sulfonylureas on long-term regulation of glucose uptake by insulin and insulin-like growth factors has been studied in the L6 line of cultured skeletal muscle cells. These cells have previously been shown to possess many characteristics of differentiated skeletal muscle and to bind and respond to physiological concentrations of insulin and insulin-like growth factors I and II. Tolazamide (half-maximal at 0.2 mg/ml) augments the effects of insulin, insulin-like growth factor I, and insulin-like growth factor II on glucose uptake, increasing both sensitivity and maximal efficacy of the hormones. In the absence of added hormone, tolazamide has no effect on glucose uptake. A similar increase in insulin-stimulated glucose uptake with unaltered basal uptake occurs with glyburide (half-maximal at 0.5 μg/ml). The action of tolazamide requires long-term exposure to the sulfonylurea (22 h) and is inhibited by cycloheximide, suggesting a process that involves new protein synthesis. In contrast to glucose uptake, amino acid uptake in L6 cells is increased by tolazamide in the absence of hormones. Insulin and the insulin-like growth factors also stimulate amino acid uptake, but this effect is not further augmented by tolazamide. Thus, sulfonylureas appear to directly modulate amino acid uptake, but to indirectly augment glucose uptake through an effect on insulin and insulin-like growth factor stimulated pathways. Neither insulin binding nor insulin degradation is altered by tolazamide, indicating a post-binding mechanism of action. The L6 cultured skeletal muscle cell line should be useful in future studies on the mechanism of the extrapancreatic actions of sulfonylureas.
Article PDF
Similar content being viewed by others
References
Loubatieres A (1944) Relations entre la structure moleculaire et l'activite hypoglycemiante des aminosulfamides hypoglycemiantes. Arch Int Physiol 54: 174–177
Pfeiffer EF, Pfeiffer M, Ditshunest H, Kahn C (1959) Clinical and experimental studies of insulin secretion following tolbutamide and metahexamide administration. Ann NY Acad Sci 82: 479–495
Levine R (1984) Sulfonylureas: background and development of the field. Diabetes Care 7: 3–7
Reaven G, Dray J (1967) Effect of chlorpropamide on serum glucose and immunoreactive insulin concentrations in patients with maturity onset diabetes mellitus. Diabetes 16: 487–492
Ward G, Harrison L, Proietto J, Aitken P, Nankervis A (1985) Gliclazide therapy is associated with potentiation of post-binding insulin action in obese non-insulin dependent diabetic subjects. Diabetes 34: 241–245
Simonson D, Ferrannini E, Stefano S, Smith D, Barret E, Carlson R, DeFronzo R (1984) Mechanism of improvement in glucose metabolism after chronic glyburide therapy. Diabetes 33: 835–838
Feldman J, Lebovitz H (1969) An insulin-dependent effect of chronic tolbutamide administration on the skeletal muscle carbohydrate transport system. Diabetes 18: 84–95
Maloff B, Lockwood D (1981) In vitro effects of a sulfonylurea on insulin action in adipocytes: potentiation of insulin-stimulated hexose transport. J Clin Invest 68: 85–90
Zuber MX, Wang SM, Thammavaram KV, Reed DK, Reed BC (1985) Elevation of the number of cell-surface insulin receptors and the rate of 2-deoxyglucose uptake by exposure of 3T3-L1 adipocytes to tolbutamide. J Biol Chem 260: 14045–14152
Vigneri R, Pezzino V, Wong KY, Goldfine ID (1982) Comparison of biguanides and sulfonylureas: effect on insulin receptors in vitro. J Clin Endocrinol Metab 54: 95–100
Prince MJ, Olefsky JM (1980) Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors. J Clin Invest 66: 608–611
Salhanick A, Konowitz P, Amatruda J (1983) Potentiation of insulin action by a sulfonylurea in primary cultures of hepatocytes from normal and diabetic rats. Diabetes 32: 206–212
Rinninger F, Kirsch D, Haring HU, Kemmler W (1984) Extrapancreatic action of the sulphonylurea gliquidone: post-receptor effect on insulin-stimulated glycogen synthesis in rat hepatocytes in primary culture. Diabetologia 26: 462–465
Gavin JR (1985) Dual actions of sulfonylureas and glyburide. Receptor and post-receptor effects. Am J Med 79 [Suppl 3 B]: 34–42
Editorial (1985) Combined sulfonylurea and insulin therapy in insulin-dependent diabetes: research or clinical practice? Diabetes Care 8: 511–514
Olefsky JM, Reaven GM (1976) Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients. Am J Med 60: 89–95
Beck-Nielsen H, Pedersen O, Lindskov HO (1979) Increased insulin sensitivity and cellular insulin binding in obese diabetics following treatment with glibenclamide. Acta Endocrinol 90: 451–462
DeFronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J (1983) Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 32: 35–45
Simpson IA, Cushman SW (1986) Hormonal regulation of mammalian glucose transport. Ann Rev Biochem 55: 1059–1089
Beguinot F, Kahn CR, Moses AC, Smith RJ (1986) The development of insulin receptors and responsiveness is an early marker of differentiation in the muscle cell line L6. Endocrinology 118: 446–455
Beguinot F, Kahn CR, Moses AC, Smith RJ (1985) Distinct biologically active receptors for insulin, insulin-like growth factor I, and insulin-like growth factor II in cultured skeletal muscle cells. J Biol Chem 260: 15892–15898
Moses AC, Nissley SP, Short PA, Rechler MM, Podskalny JM (1980) Purification and characterization of multiplication-stimulating activity. Insulin-like growth factors purified from rat-livercell conditioned medium. Eur J Biochem 103: 387–400
Yaffe D (1968) Retention of differentiation potentialities during prolonged cultivation of myogenic cells. Proc Natl Acad Sci 61: 477–483
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275
Merril G, Florini JR, Dulak N (1977) Effect of multiplication stimulating activity (MSA) on AIB transport into myoblast and myotube cultures. J Cell Physiol 93: 173–182
Jialal I, King GL, Buchwald S, Kahn CR, Crettaz M (1984) Processing of insulin by bovine endothelial cells in culture. Diabetes 33: 794–800
Yalow RS, Berson SA (1960) Immunoassay of endogenous plasma insulin in man. J Clin Invest 39: 1157–1175
Shainberg A, Yagil G, Yaffe D (1971) Alterations of enzymatic activities during muscle differentiation in vitro. Dev Biol 25: 1–29
Smith RJ, Larson S, Stred SE, Durschlag RP (1984) Regulation of glutamine synthetase and glutaminase activities in cultured skeletal muscle cells. J Cell Physiol 120: 197–203
Olefsky JM, Ciaraldi TP (1981) The insulin receptor: basic characteristics and its role in insulin-resistant states. In: Brownlee M (ed) Diabetes Mellitus, Vol 2. Garland STM Press, New York, p 73–116
Banerji M, Lebovitz HE (1986) Direct effect of sulfonylureas on amino acid transport in muscle. Diabetes 35 [Suppl 1]: 65A
Pollet RJ, Rogers BJ (1986) Effects of sulfonylurea drugs on 2-deoxy glucose transport in the BC3H-1 myocyte. Diabetes 35 [Suppl 1]: 164A
Karnieli E, Hissin PJ, Simpson IA, Salans LB, Cushman SW (1981) A possible mechanism of insulin resistance in the rat adipose cell in streptozotocin-induced diabetes mellitus. Deletion of intracellular glucose transport systems. J Clin Invest 68: 811–814
Kahn BB, Cushman SW (1985) Markedly hyperresponsive insulin-stimulated glucose uptake in adipocytes induced by insulin therapy of streptozotocin diabetic rats: increased glucose transporter number and activity. Clin Res 33: 433 A
Klip A, Li G, Logan WJ (1984) Induction of sugar uptake response to insulin by serum depletion in fasting L6 myoblasts. Am J Physiol 247: E291–296
Standaert ML, Schimmel SD, Pollet RJ (1984) The development of insulin receptors and responses in the differentiating nonfusing muscle cell line BC3H-1. J Biol Chem 259: 2337–2345
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wang, P.H., Beguinot, F. & Smith, R.J. Augmentation of the effects of insulin and insulin-like growth factors I and II on glucose uptake in cultured rat skeletal muscle cells by sulfonylureas. Diabetologia 30, 797–803 (1987). https://doi.org/10.1007/BF00275746
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00275746